Expansion and optimal Exploitation of individual neoepitope Repertoire
Cancer mutanome vaccines targeting neoepitopes derived from somatic mutations have ideal properties to become an essential part of modern multimodal cancer therapy. Our goal is to fully realize this personalized cancer immunotherapy concept by addressing the key genomic and immunological challenges for successful application of this approach in patients with any type of cancer.